Clinical Trial Information Request for Protocol 26-053 Title A Phase II Study of Time-limited Combination of Pirtobrutinib, Venetoclax, and Rituximab in Treatment Naïve Patients With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) (PRoVen) PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone